insights_auto
Outlook: 80.0% bullish·0.0% bearish
Go to analysischevron_right
BCRX:NASDAQ
BioCryst Pharmaceuticals Inc
$7.63
arrow_downward
-0.78%(-0.060) 1D
$7.59
arrow_downward
-0.52% (-0.040)todayPre-market
Closed: Nov 9, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
Analyst ratings
Based on 6 analysts giving stock ratings to BCRX in the past 3 months
Buy
Buy
4
Hold
2
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for BCRX in the last 3 months.
Highest
Current $7.63
$30.00 (+293.18%)
Average
$17.00 (+122.80%)
Lowest
$11.00 (+44.17%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Brian Abrahams RBC Capital | Hold | Maintained | $11.00 | +44.2% | 11/04/2026 |
Laura Chico Wedbush | Buy | Maintained | $17.00 | +122.8% | 11/05/2026 |
Stacy Ku TD Cowen | Buy | Maintained | $30.00 | +293.2% | 10/21/2026 |
Tazeen Ahmad Bank of America Securities | Buy | Reiterated | $15.00 | +96.6% | 10/09/2026 |
Jessica Fye J.P. Morgan | Hold | Reiterated | $13.00 | +70.4% | 09/30/2026 |
Serge Belanger Needham | Buy | Maintained | $16.00 | +109.7% | 09/08/2026 |
Unknown Analyst Evercore ISI | Buy | Maintained | $17.00 | +122.8% | 08/10/2026 |
Andrew Fein H.C. Wainwright | Buy | Maintained | $32.00 | +319.4% | 08/06/2026 |
Steven Seedhouse Cantor Fitzgerald | Buy | Maintained | $29.00 | +280.1% | 06/30/2026 |
Jonathan Wolleben Citizens JMP | Buy | Maintained | $28.00 | +267% | 05/07/2026 |
Gavin Clark-Gartner Evercore ISI | Buy | Initiated | $17.00 | +122.8% | 02/18/2026 |